The female carrier of this pathogenic variant in Family 13 had gastric cancer and was assessed for pathogenic variants in other genes; after the variant in the BRCA1 gene was identified, the patient underwent surveillance, and breast and ovarian cancer were detected. This evidence concerns the gene BRCA1 and ovarian carcinoma.